(Q38438519)

English

Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial

scientific article published on 28 May 2011

Statements

Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial (English)
Raymond Hupperts
Luigi M E Grimaldi
Peter Rieckmann
Myriam Schluep
Ulrike Hostalek
Lizette Ghazi-Visser
Manolo Beelke
SOLAR study group
28 May 2011
44-49

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit